1. Introduction {#s0005}
===============

The SARS-CoV-2 is the causative agent of the COVID-19 disease. A coronaviridae enveloped positive-sense single-stranded RNA virus. Its main transmission pathway is through large respiratory droplets and direct and indirect contact. Phylogenetic analyses indicate a close relation to bat SARS-like and MERS-like coronavirus(Tang et al. 2020a). The first 9 cases of SARS-CoV-2 were analysed, sequences of the virus were more than 99.98% similar between them. SARS-CoV-2 share at least 88% of genetic sequence similarities with SARS-Like Coronaviruses and share 79% similar sequence identity with SARS-CoV and MERS-COV about 50%, additionally, SARS-CoV-2 have similar receptor binding domain structure compared with SARS-CoV(Lu et al. 2020; Wang et al. 2020c). Therefore, despite survival time and conditions affecting SARS-CoV-2 remains unknown, it is plausible to extrapolate knowledge from SARS-CoV family; it is a zoonotic bat originated virus; from the family of Severe Acute Respiratory Syndrome-Coronavirus (SARS-CoV) and Middle East Respiratory Syndrome-Coronavirus (MERS-CoV)(Song et al. 2019); and capable of survive several days in the environment(Otter et al. 2016; European Centre for Disease Prevention and Control 2020).

The emergence of this novel coronavirus (SARS-CoV-2) on December 2019 in Wuhan, Hubei province of China, is having a significant impact over the world, counting and summing cases in every continent in only a few months(Tang et al. 2020a; Wang et al. 2020a). According to the World Health Organization (WHO) situation report 179(World Health Organisation), up to 17^th^ July 2020 the pandemic have killed 585,727 people with cases reported in 216 countries. Due to its significant impact, the emergence of this novel coronavirus has been declared a global health emergency. The fast and worldwide spreading of the virus points at a human-to-human transmission.

SARS-CoV gained attention after the 2003 pandemic(Drosten et al. 2003; Ksiazek et al. 2003) that killed 774 individuals in 24 countries and later in 2012 MERS-CoV killed 858 across 25 countries. Since then, some studies have described virus characteristics(Yip et al. 2007). Its influenza-like symptoms are non-specific and may include cough, breathing difficulties, runny nose, fever and headache. Laboratory exam shows lymphopenia and bilateral ground-glass opacity or consolidation CT scans, making difficult differential diagnostic against influenza or other respiratory viruses(Wang et al. 2020a). Unlike influenza, these symptoms seem to last longer in SARS-CoV-2 infection(Tang et al. 2020a), becoming a life-threatening condition for specific risk groups, such as immune-compromised and older patients. Several treatments are currently under study, being the most promising the use of remdesivir and chloroquine(Wang et al. 2020b). Other medications are also under study with fewer positive results, such as hydroxychloroquine(Gao et al. 2020; Tang et al. 2020b) and azithromycin (Gautret et al. 2020) in combination with hydroxychloroquine.

Since the 2019-nCoV-2 outbreak, extraordinary public health measures have been implemented around the globe to help reduce virus spreading. These measures mainly point at people's transport restriction including quarantine of suspicious cases, airport and public transport closure, massive events cancellation, and social distancing and isolation. Preventing campaign has been launched by several world-leading agencies(Public Health England; World Health Organisation; CDC 2020) and from almost every governmental Health Department. Preventing actions, such as frequent hand-washing, correct mouth-covering when coughing and use of masks are common indications have given way to increasingly restrictive measures aiming to social distancing and isolation.

Recent investigations have found novel and effective ways of decreasing the risk of transmission of several respiratory viruses from the coronaviridae and influenza family, such as the use of copper(Borkow et al. 2010, 2011; Fujimori et al. 2012; Imai et al. 2012; Majbauddin et al. 2015; Warnes et al. 2015; Ito et al. 2016; Minoshima et al. 2016; Zerbib et al. 2020). Copper has been used in clinical settings to reduce the risk of bacterial and viral contamination, complementing traditional protocols. Furthermore, the addition of copper nanoparticles to polymer/plastic matrices can also produce highly effective antimicrobial materials. This review highlights the results of the research studying the effect of copper over the coronaviruses and influenza, summarising the state-of-the-art related its antiviral properties.

2. Methods {#s0010}
==========

PubMed and Ovid servers were used without date or language restrictions. The PICOS method was followed to identify suitable terms. Table I describes the PICOS analysis. The search was carried out on March 7^th^, 2020 using the following search terms \[Copper\] Coronavirus OR CoV OR SARS OR MERS OR Influenza. The search yielded a total of 110 articles. Duplicates items were eliminated remaining 88 studies. Title and abstract elimination left 11 suitable articles with the defined outcome and study design for full analyses. [Figure 1](#f0005){ref-type="fig"} describes the search phases. (See [Table 1](#t0005){ref-type="table"} .)Figure 1Phases of studies selectionFigure 1Table 1PICOS description for key terms identificationTable 1DescriptionIdentifierPPatient, population or diseaseSARS-Cov, CoronavirusIInterventionCopperCComparison groupMERS-CoV; InfluenzaOOutcomeInactivation, expositionSStudy type, designClinical and laboratory trials, prospective

3. Results and Discussion {#s0015}
=========================

Excluded titles included: 32 did not refer to copper properties, 25 refer to other viruses or bacteria, 7 epidemiological/demographic studies, and 13 other different criteria. Several studies have described the antimicrobial and antiviral properties of copper over a variety of pathogens. [Table II](#t0010){ref-type="table"} summarises the identified studies related to copper and respiratory viruses.Table IIStudies about the copper effect on respiratory virusesTable IINAuthorYearVirusSubstrateMediaResults1Miyamoto1998Influenza (H1N1, H2N2, H3N2)Copper chelatesMadin--Darby canine kidney (MDCK)5μM Copper inhibits apoptosis of the 98 to 100% influenza virus, independent of the influenza type. Inhibited viruses release during apoptosis2Han2005SARS-Cov, E. coliCu/AI203Metal catalyst surfaceAfter 5 minutes of exposure, the infectivity dropped down to undetectable levels3Noyce2007Influenza (H1N1)Stainless steel and copperMetal surface500,000 virus particles remain infectious after 24 h incubation on stainless steel, 500 particles were active after 6 hours on copper incubation.4Horie2008Influenza (H9N2)Cu^2+^ at 2.5-250μM concentrationsMadin--Darby canine kidney (MDCK)titer reduction of 3 and 4 log within 3 and 6 hours exposure5Borkow2010Influenza (H1N1, H9N2)Copper oxideImpregnated cotton textileafter 30 minutes of simulated breathing, 5.03±0.54 log~10~TCID~50~ virus titers were recovered from control masks. No influenza titers were found on copper oxide containing masks (≤0.88 log~10~TCID~50~)6Imai2012Influenza (H5N1, H5N3)Cu^2+^ (0.1 ml)Impregnated cotton textileTiters of H5N1 decreased by \>5.0 log~10~ and 5.0 log~10~, respectively after 30 s. incubation on the textile. H5N3 decreased at similar rates.7Fujimori2012Influenza (H1N1)nanosized copper iodide (CuI)aqueous solution concentration dose. 17μ/mLCuI particles (17μg/ml) in PBS after one-hour exposure inactivates virus by hydroxyl radicals' action.8Warnes2015SARS-Cov (HuCoV-229E)Copper alloy surfacesDifferent dry surface10^3^ Plaque Forming Units (PFU) in simulated wet-droplet contamination (20μl per cm^2^) was inactivated in less than 60 min. Further analyses revealed a lag in inactivation after 10min (approx.)9Minoshima2016Influenza (H1N1) and bacteriophage Qβ.ionic copper and silver cuprous oxide (Cu~2~O)solid-state and soluble compoundsSolid-state of cuprous oxide (Cu~2~O) inactivates influenza A virus and bacteriophage Qβ, however; solid-state cupric oxide (CuO) and silver sulphide had a little antiviral effect10Ito2016Influenza (H1N1) and HIV (Type-1)sodium copper chlorophyllinMadin--Darby canine kidney (MDCK)Sodium copper chlorophyllin inhibited HIV adsorption at 2.5 mM (*P* \< 0.05) and inhibited the influenza virus adsorption at 200 μM (*P* \< 0.05).11Zerbib2020Hand-transmitted healthcare-associated infectionCopper alloy surfacesDifferent dry surfaceThe relative risk of hand-transmitted healthcare-associated infection was significantly lower in the copper equipped surface (RR 0.3, 95% CI 0.1-0.5).

A prospective observational pilot study (Zerbib et al. 2020) in a nursing home for older adults setting, studied the antimicrobial properties of copper, comparing copper equipped versus not equipped surfaces. Researchers randomly equipped with copper alloy (containing 90% copper) door handles, handrails and grab-bars of 2 out of 4 areas of the building, all areas were equal in terms of the type of patients. Flu caused by Influenza A, gastroenteritis by norovirus and keratoconjunctivitis and gastroenteritis by unidentified pathogens (possibly adenovirus and norovirus respectively) were the outbreaks occurring the study period. The outbreaks of Keratoconjunctivitis and gastroenteritis were significantly lower in the equipped with copper areas. The relative risk of hand-transmitted healthcare-associated infection (adenovirus and norovirus) was significantly lower in the copper equipped surface (RR 0.3, 95% CI 0.1-0.5). This indicates that copper reduces the incidence of infection in the healthcare context. This effect related to surface contact transmission. Airborne transmission, to some extent, may be affected by equipping common use areas with copper surfaces.

Most of the research about the use of copper or copper alloy is related to influenza virus. Noyce(Noyce et al. 2007) studied the effect of copper over influenza virus: 20μl of virus (10^8^ particles) were inoculated into copper or stainless steel; about 500,000 virus particle remained infectious after 24 hours incubation on stainless steel, on the other hand, after 6 hours on copper incubation only 500 particles remained viable. Similarly to Zerbib(Zerbib et al. 2020) study; influenza may not be prevented by replacing steel fittings with copper; however, copper may reduce transmission. Miyamoto(Miyamoto et al. 1998) in a laboratory model, demonstrated that copper chelates inhibit apoptosis of the influenza virus, and such effect is independent of the influenza type. Additionally, copper chelates inhibited viruses release during apoptosis. Minoshima(Minoshima et al. 2016), compare the effect of solid-state and soluble ionic copper and silver compounds against influenza A (A/PR8/H1N1) and bacteriophage Qβ. Solid-state of cuprous oxide (Cu~2~O) inactivates influenza A virus and bacteriophage Qβ. Hemagglutinin (HA) and neuraminidase (NA) are proteins highly involved in the influenza infection process by binding with the host cell and allowing the release of viruses. These proteins are expressed by a hundred on the surface of the virus envelope; CU~2~O decreased the HA titer below the detection limit within 30 min and NA activity was significantly reduced after 10 min. Higher activity against viruses was reported for Solid-state Cu~2~O compared to silver compounds, meaning a low-cost and widely available product usable in public places and health facilities. Imai(Imai et al. 2012), studied the effect of cotton textiles containing Cu^2+^ (CuZeo-textile) over a highly pathogenic H5N1 and the low pathogenic H5N3 viruses; titers of H5N1 decreased by \>5.0 log~10~ and 5.0 log~10~, respectively after 30 s. incubation on the textile. Horie(Horie et al. 2008), demonstrated H9N2 virus titer reduction of 3 and 4 logs within 3 and 6 hours exposition to Cu^2+^ at concentrations of 2.5-250μM. Fujimori(Fujimori et al. 2012) examined the antiviral properties of nanosized copper iodide (CuI) in aqueous solution against influenza A virus (H1N1). Virus titers decreased depending on concentration dose from 0 to 1000 μ/ml, resulting in a 50% effective concentration dose at 17μ/ml after one-hour exposure. The authors hypothesize that Cu^+^ may inactivate viruses by oxidizing lipids; lipids are the main components of enveloped influenza viruses. The authors claimed that these properties can be applied to filters, masks and clothing by mixing or coating polymers base materials. Ito(Ito et al. 2016) in a laboratory model shown that sodium copper chlorophyllin had antiviral effect against influenza and HIV. Copper chlorophyllin inhibits the virus-to-cell interaction on the cell surface and this mechanism has been described for several microbes(Benati et al. 2009; Majbauddin et al. 2015).

Few but conclusive studies have focused on the antiviral properties of copper against coronavirus. Han(Han et al. 2005) studied the effect of metal catalysts of Cu/Al203 against SARS-CoV, baculovirus and E. Coli. After 5 minutes of exposure, the infectivity dropped down to undetectable levels. SARS-CoV inactivation was achieved only when the loading viruses on the surfaces were exposed to air. Considering that central air conditioning systems are known pathways for infectious agents; the author concludes that the capacity to inactivate viruses or bacteria in the air filtered by AC systems depends on the efficient usage of oxygen, having the potential to disinfect the air in community settings and health services.

Human SARS and MERS coronavirus, as well as H1N1, H5N1 and H5N7 influenza viruses share an important number of characteristics. These viruses are RNA respiratory viruses from zoonotic origins that have mutated for human-to-human transmission by droplets of about 5μm of diameter. These droplets may directly contact the nose, mouth or eyes of the recipient. Indirect contact, involving contaminated surfaces(Bridges et al. 2003; Boone and Gerba 2007) is also a predominant transmission route(Brankston et al. 2007; Spicknall et al. 2010). These respiratory viruses are the main cause of deaths among any other infectious agent(Warnes et al. 2015).

One of the causes of the high rate of transmission of respiratory viruses relates with it capability to survive on dry surfaces for more than five days on a variety of daily use surfaces, such as ceramic tiles, glass, rubber and stainless steel(Warnes et al. 2015). Nevertheless, it has also been reported that, depending on the surface, the SARS coronavirus, MERS coronavirus and HCoV can remain infectious for up to 9 days, and for up to 28 days at 4°C(Kampf et al. 2020). Thus, the virus can survive for a considerably long time until a person touches a surface contaminated by respiratory droplets from an infected individual. In 2015 the study by Warnes(Warnes et al. 2015) showed conclusive results related to the effect of copper on HCoV 229E. HCoV 229E remain infectious for at least 5 days on nonmetal surfaces such as Teflon, PVC, ceramic tiles, glass, silicone rubber and stainless steel. On the other hand, when exposed to copper (metal surface) and copper alloy (Cu/Zn brasses) after 10 minutes of exposition viral genomes and morphology were irreversibly affected. Warnes described rapid damage to the surface proteins and membrane, breaking the envelope or losing its capacity of self-containing folding upon itself. Coronavirus genomic RNA after copper exposure revealed nonspecific fragmentation, and this pattern of damage increased as exposure time increased.

Some application designs of this knowledge have been successfully tested; Borkow (Borkow et al. 2010) developed a face mask impregnated with copper oxide and tested its antiviral effects against influenza (H1N1 and H9N2). Above 99.85% of aerosolized viruses were filtered by both control and copper oxide impregnated masks. Nevertheless, after 30 minutes of simulated breathing, 5.03±0.54 log~10~TCID~50~ was recovered from control masks. No infectious influenza was found on copper oxide containing masks (≤0.88 log~10~TCID~50~)

Borkow et al(Borkow et al. 2011), used powder copper oxide (of about 18μm) to inactivate HIV in 5 minutes and following a mathematical model; estimated that using nanoparticles (of about 1μm) would reduce that time to only 14 seconds. Copper nanoparticles have been preliminarily tested against HIV, and as predicted by Borkow, the needed time to inactivate the virus was about 15 seconds -unpublished data-(Copper3).

4. Conclusion {#s0020}
=============

A variety of respiratory pathogenic agents such as influenza, SARS-CoV, MERS-CoV and HCoV, have been exposed to a variety of copper forms (Copper alloy dry surface, sodium copper, ionic copper oxide, copper iodide, Cu^2+^ and lay copper) in several cultivating media (MDCK, metal, textile, aqueous solution, dry surfaces) having similar results and arriving at the same conclusion: Copper is capable to inhibit, inactivate, reduce and irreversibly destroy coronavirus, influenza virus and other pathogenic agents in a matter of minutes. A recent study has evaluated and compared SARS-CoV-1 and SARS-CoV-2 stability and decay rates in aerosols, copper (metallic plate at 99% of copper), cardboard, stainless steel and plastic. Despite significant reduction on infectivity of SARS-CoV 1 and SARS-CoV 2 after 3 hours in aerosols, 72 hours on plastic and 48 hours on stainless steel the virus remained infectious. On the other hand, after exposition on copper; no viable virus was observed after 8 hours and after 4 hours of SARS-CoV-1 and SARS-CoV-2 respectively (van Doremalen et al. 2020). Perhaps, these data suggest a higher effect of copper on SARS-CoV-2. Based on the reviewed literature; copper nanoparticles together with efficient usage of oxygen appears to be the most effective formulation against Coronaviruses.

The described data appears to support the use of copper in different presentations to actively inactivate viruses (and a wide range of microorganisms) and seems to be an effective and low-cost complementary strategy to help reducing transmission of several infectious diseases such as the coronavirus. Nevertheless, and despite the genetic similarities, more research would be beneficial to support its usage with the new SARS-Cov-2.

However, the described data support the incorporation of copper alloys or impregned copper materials on health services as a complementary strategy that may help reduce bacterial and viral load, therefore; limiting nosocomial infections and reducing transmission from touching surfaces in the communal city or home areas(Prado J et al. 2012; Warnes et al. 2015).

Additionally, copper oxide or nano-compounds may be used as filters, face masks, clothing and hospital common use devices to reduce viruses and bacterial incubation(Fujimori et al. 2012). Some copper product application has been tested with conclusive results, describing copper potent antiviral properties, reducing disease spreading by limiting environmental contamination and subsequent infections(Borkow et al. 2010).
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